Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. Forging a new path towards a safe and effective treatment for Alzheimer’s disease.

September is World Alzheimer's Month, and for the fourth year, we are honored to support the Alzheimer's Association 'Wa...
09/01/2026

September is World Alzheimer's Month, and for the fourth year, we are honored to support the Alzheimer's Association 'Walk to End Alzheimer's' campaign. This commitment allows us to come together as a united force, advocating for a cause that is not only close to our hearts but also at the core of what we do.

Despite our geographical distance, we're all one Acumen team, and we're hitting the pavement in our local walks.

If you'd like to learn more about how you can support the Acumen team, click the link below:
https://lnkd.in/gReXFrYY

Happy National Dog Day! Dogs make our lives better in countless ways, from helping us unwind after a long day to creatin...
08/26/2026

Happy National Dog Day!

Dogs make our lives better in countless ways, from helping us unwind after a long day to creating moments of laughter and connection with our families.

Today, we're spotlighting some of the dogs that are part of the Acumen team and celebrating the joy they bring to those around them.

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredi...
08/17/2026

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredible team members and the amazing work they do!

August's 'Ask Acumen' featured team member is Amy Hutchinson, Manager, CMC Quality Assurance.

🔗Click the link to get a behind-the-scenes look at Amy's journey, passions, and outstanding contributions to our mission: https://acumenpharm.com/ask-acumen/

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredi...
07/20/2026

At Acumen, we believe in putting people first, and what better way to do that than by shining a spotlight on our incredible team members and the amazing work they do!

July's 'Ask Acumen' featured team member is Drew Haigh, Clinical Trial Assistant.

🔗Click the link to get a behind-the-scenes look at Drew's journey, passions, and outstanding contributions to our mission: https://acumenpharm.com/ask-acumen/

All good things must come to an end, and while the Acumen team is sad to leave , it’s been a wonderful week of sharing ...
07/16/2026

All good things must come to an end, and while the Acumen team is sad to leave , it’s been a wonderful week of sharing knowledge and innovation in the ’s field. We’ll see you all next year at Alzheimer's Association International Conference in Chicago!

This week at , Stephanie Cline presented findings from a patient interview study conducted with participants and study ...
07/16/2026

This week at , Stephanie Cline presented findings from a patient interview study conducted with participants and study partners in our Phase 2 ALTITUDE-AD trial. This work helps deepen our understanding of the lived experience of early Alzheimer's disease and what matters most to patients.

You can view the poster through the AAIC platform or on our website.

Link: https://acumenpharm.com/publications/

It's been a wonderful week at connecting with colleagues, researchers, and friends from across the Alzheimer's communi...
07/16/2026

It's been a wonderful week at connecting with colleagues, researchers, and friends from across the Alzheimer's community. We're especially grateful for the chance to spend time in person with so many individuals dedicated to accelerating progress in Alzheimer's disease.

The energy and momentum in the field are truly inspiring, and we're proud to contribute to the work pushing innovation forward.

Today at , Paul Shughrue presented data from our Enhanced Brain Delivery™ (EBD™) program, showcasing advancements in br...
07/15/2026

Today at , Paul Shughrue presented data from our Enhanced Brain Delivery™ (EBD™) program, showcasing advancements in brain delivery technology and progress toward next-generation anti-AβO therapeutics for Alzheimer's disease.

Learn more: https://acumenpharm.com/publications/

We're pleased to share new data presented at the Alzheimer's Association International Conference (AAIC®) 2026 highlight...
07/15/2026

We're pleased to share new data presented at the Alzheimer's Association International Conference (AAIC®) 2026 highlighting advancements from our Enhanced Brain Delivery™ (EBD™) program and insights from participants in our Phase 2 ALTITUDE-AD study.

Presentations included:
🔹 New preclinical data from our Enhanced Brain Delivery™ (EBD™) program
🔹 Progress toward next-generation anti-AβO therapies
🔹 Perspectives from participants in the ALTITUDE-AD study

🔗 Explore the data and read our press release: https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-highlights-enhanced-brain-deliverytm-0

Address

Newton, MA

Telephone

+14342971000

Website

Alerts

Be the first to know and let us send you an email when Acumen Pharmaceuticals, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Acumen Pharmaceuticals, Inc.:

Shortcuts

Share

Category